Treatment
Fdg clinical trials
We’re tracking 153 recruiting studies that include Fdg, each written for real people, not researchers, below.
Recruiting studies
- NCT07625150Recruiting
PET/MRI Imaging Study of Kneecap Joint Osteoarthritis
This research study uses advanced imaging (PET and MRI scans) to better understand osteoarthritis in the front of the knee, where the kneecap meets the thighbone. You'll help researchers learn how to detect and track this condition earlier.
San Francisco, CaliforniaAges 18 years+ - NCT07632092Recruiting
Brain Imaging Study After Radiotherapy for Cancer Spread
This study uses a special type of brain scan (PET imaging) to better understand how cancer that has spread to the brain responds to radiation treatment. The scan may help doctors see which patients are responding well to treatment.
AmiensAges 18 years+ - NCT07041372Enrolling by invitation
Brain PET Study for Recent Stroke Patients
This study uses a special brain scan (PET) to learn more about how artery hardening (atherosclerosis) affects stroke. It is for people who have just had a stroke and may help doctors understand the disease better.
Seoul, Jong-ro GuAges 19 years+ - NCT07023861Enrolling by invitationEarly Phase 1
New imaging test for HER2-positive cancers
This trial tests a new imaging method that uses a radioactive tracer to find HER2-positive cancer cells in the body. It may help doctors see tumors more clearly in people with stomach, breast, or bladder cancer.
Wuxi, JiangsuAges 15–75 - NCT07023848Enrolling by invitationEarly Phase 1
Imaging study for HER2-positive cancers using a special tracer
This study uses a radioactive tracer to take pictures of tumors that have a protein called HER2. It may help doctors see where the cancer is in your body and could guide future treatment decisions.
Wuxi, JiangsuAges 18–75 - NCT06723665Enrolling by invitation
PET/CT scan for prostate cancer patients
This study uses a special type of PET/CT scan called 18F-PSMA-1007 to take detailed pictures of prostate cancer. It's for people who might have prostate cancer, have been diagnosed, or need to check how their cancer is doing after treatment.
Wuxi, JiangsuAges 40–75 - NCT05160480Enrolling by invitation
Total-body PET scan using FDA-approved tracers for prostate or NET cancer
This pilot study tests a total-body PET scan with approved tracer medicines to help detect cancer spread in people with suspected metastatic prostate cancer or certain neuroendocrine tumors (NETs). You may be able to join if recent scans already suggest metastasis and you can safely complete the scan timing and positioning.
Sacramento, CaliforniaAges 18 years+ - NCT05108857Enrolling by invitation
PET scan study for early active systemic sclerosis
This trial uses PET/CT scans with special tracers to look at inflammation and activity in systemic sclerosis (scleroderma) soon after symptoms begin. It may help researchers understand what’s driving active disease and where it shows up in the body.
TurkuAges 18 years+ - NCT05015881Enrolling by invitationPhase 2/Phase 3
Brain and heart scans in alcohol use disorder
This study uses special brain and heart scans to see how sugar (glucose) is used in people with alcohol use disorder compared with people without it. It may help researchers understand the brain–heart connection in alcohol use disorder.
Philadelphia, PennsylvaniaAges 21–65
Common questions
- Are there clinical trials studying Fdg?
- Yes. Clin2 currently lists 153 recruiting studies that include Fdg, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Fdg trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Fdg an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Fdg or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.